Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

306 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sex differences in lung imaging and SARS-CoV-2 antibody responses in a COVID-19 golden Syrian hamster model.
Dhakal S, Ruiz-Bedoya CA, Zhou R, Creisher P, Villano J, Littlefield K, Castillo J, Marinho P, Jedlicka A, Ordonez A, Majewska N, Betenbaugh M, Flavahan K, Mueller A, Looney M, Quijada D, Mota F, Beck SE, Brockhurst JK, Braxton A, Castell N, D'Alessio F, Metcalf Pate KA, Karakousis PC, Mankowski JL, Pekosz A, Jain SK, Klein SL. Dhakal S, et al. Among authors: pekosz a. bioRxiv [Preprint]. 2021 Apr 4:2021.04.02.438292. doi: 10.1101/2021.04.02.438292. bioRxiv. 2021. Update in: mBio. 2021 Aug 31;12(4):e0097421. doi: 10.1128/mBio.00974-21 PMID: 33821269 Free PMC article. Updated. Preprint.
Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Infectious Virus Loads Compared to the Alpha Variant in both Unvaccinated and Vaccinated Individuals.
Luo CH, Morris CP, Sachithanandham J, Amadi A, Gaston D, Li M, Swanson NJ, Schwartz M, Klein EY, Pekosz A, Mostafa HH. Luo CH, et al. Among authors: pekosz a. medRxiv [Preprint]. 2021 Aug 20:2021.08.15.21262077. doi: 10.1101/2021.08.15.21262077. medRxiv. 2021. Update in: Clin Infect Dis. 2022 Aug 24;75(1):e715-e725. doi: 10.1093/cid/ciab986 PMID: 34462756 Free PMC article. Updated. Preprint.
Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection.
Park HS, Shapiro JR, Sitaras I, Woldemeskel BA, Garliss CC, Dziedzic A, Sachithanandham J, Jedlicka AE, Caputo CA, Rousseau KE, Thakar M, Suwanmanee S, Hauk P, Aliyu L, Majewska NI, Koley S, Patel B, Broderick P, Mosnaim G, Heath SL, Spivak ES, Shenoy A, Bloch EM, Gniadek TJ, Shoham S, Casadevall A, Hanley D, Cox AL, Laeyendecker O, Betenbaugh MJ, Cramer SM, Mostafa HH, Pekosz A, Blankson JN, Klein SL, Tobian AA, Sullivan D, Gebo KA. Park HS, et al. Among authors: pekosz a. JCI Insight. 2022 Mar 8;7(5):e155944. doi: 10.1172/jci.insight.155944. JCI Insight. 2022. PMID: 35104245 Free PMC article.
A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads.
Fall A, Eldesouki RE, Sachithanandham J, Morris CP, Norton JM, Gaston DC, Forman M, Abdullah O, Gallagher N, Li M, Swanson NJ, Pekosz A, Klein EY, Mostafa HH. Fall A, et al. Among authors: pekosz a. medRxiv [Preprint]. 2022 Jan 28:2022.01.26.22269927. doi: 10.1101/2022.01.26.22269927. medRxiv. 2022. Update in: EBioMedicine. 2022 May;79:104008. doi: 10.1016/j.ebiom.2022.104008 PMID: 35118480 Free PMC article. Updated. Preprint.
A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variants.
Jiang L, Driedonks TAP, Jong WSP, Dhakal S, van den Berg van Saparoea HB, Sitaras I, Zhou R, Caputo C, Littlefield K, Lowman M, Chen M, Lima G, Gololobova O, Smith B, Mahairaki V, Richardson MR, Mulka KR, Lane AP, Klein SL, Pekosz A, Brayton CF, Mankowski JL, Luirink J, Villano JS, Witwer KW. Jiang L, et al. Among authors: pekosz a. bioRxiv [Preprint]. 2022 Feb 1:2021.06.28.450181. doi: 10.1101/2021.06.28.450181. bioRxiv. 2022. Update in: J Extracell Vesicles. 2022 Mar;11(3):e12192. doi: 10.1002/jev2.12192 PMID: 35132418 Free PMC article. Updated. Preprint.
A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variants.
Jiang L, Driedonks TAP, Jong WSP, Dhakal S, Bart van den Berg van Saparoea H, Sitaras I, Zhou R, Caputo C, Littlefield K, Lowman M, Chen M, Lima G, Gololobova O, Smith B, Mahairaki V, Riley Richardson M, Mulka KR, Lane AP, Klein SL, Pekosz A, Brayton C, Mankowski JL, Luirink J, Villano JS, Witwer KW. Jiang L, et al. Among authors: pekosz a. J Extracell Vesicles. 2022 Mar;11(3):e12192. doi: 10.1002/jev2.12192. J Extracell Vesicles. 2022. PMID: 35289114 Free PMC article.
Evolution of nasal and olfactory infection characteristics of SARS-CoV-2 variants.
Chen M, Pekosz A, Villano JS, Shen W, Zhou R, Kulaga H, Li Z, Beck SE, Witwer KW, Mankowski JL, Ramanathan M Jr, Rowan NR, Lane AP. Chen M, et al. Among authors: pekosz a. bioRxiv [Preprint]. 2022 Apr 12:2022.04.12.487379. doi: 10.1101/2022.04.12.487379. bioRxiv. 2022. Update in: J Clin Invest. 2024 Mar 14;134(8):e174439. doi: 10.1172/JCI174439 PMID: 35441175 Free PMC article. Updated. Preprint.
306 results